University of Florida Proton Therapy Institute
Jacksonville, Florida 32209
2 studies enrolling now · 33 studies all time
What they study most
Age-Related Macular Degeneration, Brain Cancer, Breast Cancer, Cancers of Nasal Cavity, Cancers of Paranasal Sinuses, Carcinoma, Squamous Cell, Central Nervous System Tumors, Chondrosarcomas, Chordomas, Esophageal Cancer, Head and Neck Neoplasms, Hodgkin Lymphoma
Studies at this site
- Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy — Recruiting now
- Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy — Recruiting now
- Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas — Recruiting now
- Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy — Running, not enrolling
- A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer — Running, not enrolling
- A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer — Running, not enrolling
- Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer — Completed
- Study of Cardiac MRI in Patients With Left-Sided Breast Cancer Receiving Radiation Therapy — Completed
- P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC — Completed
- Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer — Completed
- Proton Therapy for Low and Intermediate Risk Prostate Cancer — Completed
- Radiotherapy for Oligometastatic Prostate Cancer — Completed
- Outcomes Study of Late Effects After Proton RT for Pediatric Tumors of the Brain, Head, and Neck — Completed
- Proton Therapy for Stage I Non-Small Cell Lung Cancer (LU03) — Completed
- Proton Therapy for Hodgkin Lymphoma — Completed
- Dose Escalated Proton Beam Therapy or Photon Therapy for Esophageal Cancer — Withdrawn before enrolling
- Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32) — Withdrawn before enrolling
- Proton Therapy for Lymph Nodes in Breast Cancer — Completed
- Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01) — Stopped early
- Proton Radiation Therapy for Macular Degeneration — Completed
- Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02) — Stopped early
- Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer — Completed
- Proton Radiation for Resectable Carcinoma of the Pancreas — Completed
- Proton Therapy for Unresectable Cancer (CA) of Pancreas — Completed
- Proton Therapy for Chordomas and/or Chondrosarcomas — Completed
- Photon/Proton Radiation Therapy for Cancers of the Nasal Cavity and/or Paranasal Sinuses — Completed
- Photon/Proton Radiation Therapy for Carcinoma of the Nasopharynx — Stopped early
- Preoperative Proton Radiotherapy for Retroperitoneal Sarcoma — Stopped early
- Photon/Proton Radiation Therapy for Carcinoma of the Skin of the Head and Neck — Stopped early
- Photon/Proton Radiation Therapy for Oropharyngeal Cancers — Stopped early
- Semen Analysis After Proton Therapy for Prostate Cancer — Completed
- Camera Based System to Monitor Patient Movement During Radiation Treatment — Stopped early
- Proton Radiation Therapy for Pituitary Adenoma — Stopped early